Xenotransplantation –View of the Transplanted Patient

Total Page:16

File Type:pdf, Size:1020Kb

Xenotransplantation –View of the Transplanted Patient Acta vet. scand. 2002, Suppl. 99, 59-63. Xenotransplantation –View of the Transplanted Patient By Ragnar Skjøld The Norwegian Kidney Patients Association (LNT), P.O.box 4332 Nydalen, NO-0402 Oslo and the Norwegian Organ Donation Foundation, P.O. box 4375 Nydalen, NO-0402 Oslo, Norway. Tel: +47 22 79 92 92, E-mail: [email protected] Introduction First of all, I would like to express my gratitude In my presentation I will deal with the follow- to the Nordic NKVet committee for inviting me, ing aspects: the patient, to present my view on xenotrans- 1. The current transplantation activities in Nor- plantation in this forum, particularly, since way many of you show concern for the animals that 2. The present challenge of organ transplanta- by means of necessity are involved in this pro- tion- and the ideal transplantation from the cess. patient's point of view I also represent the patient organisation LNT - 3. Stiftelsen Organdonasjon – (Norwegian Or- Landsforeningen for Nyrepasienter og Trans- gan Donation Foundation) planterte, (in English: The Norwegian Kidney - informing the public on organ donation- what Patients Association) which is an organisation has been done so far? currently representing its 3.000 members of pa- 4. Xenotransplantation – is this the way to go? tients with kidney diseases, or who have re- 5. The prospects of using stem cells in trans- ceived organ transplants in Norway. plantations Further, I represent Stiftelsen Organdonasjon 6. Conclusions – what to do? (in English: Norwegian Organ Donation Foun- dation) of which I am a board member. This or- 1. The current transplantation activities in ganisation has as its most prominent task to Norway work on information on organ donation and to Historically, the man Christiaan Barnard in increase public awareness of the possibility to South-Africa in 1967 was important. He made donate one's organs after death. the first heart transplant carried out on a human I have received organ transplants myself on two being in the world, and this is an incidence that occasions; I myself remember well from the radio news – first time was way back in 1978 when I re- from when I was a boy. ceived a kidney from my mother In Norway kidney transplantation was offered – second time, in 1995 when I received a kid- at a very early date, since routine transplanta- ney from a deceased person (necrokidney) tions were carried out here already in1969. Rik- With this in mind I will try to convey the view shospitalet, The national hospital, is the only of the transplanted patient. transplant unit in Norway, which is understand- Acta vet. scand. Suppl. 99 - 2002 60 R. Skjøld able in a country with little over 4.5 million Thus, the greatest current challenge in trans- people, but which makes the activities particu- plantation is to get enough human organs for larly vulnerable. Presently, almost 4000 necro- transplantations as soon as possible. In the en- organs have been transplanted at Rikshospitalet tire western region of the world the waiting lists since the start in 1969. are dramatically increasing. Thus, lack of avail- Transplantation until now has had only one ma- able organs is the greatest motivator to innova- jor goal-which is patient survival. As patients, tion. Alternatives to human organ transplants, we are also concerned with the quality of life such as xenotransplantation and stem cell ther- after the transplantation. With this I specifically apy, are necessary to save human lives. Repre- mean a long life expectancy with a reasonable sentatives of Rikshospitalet have declared, that freedom from pain and other serious side ef- the prevalence (frequency of a disease) of pa- fects. This is an area, which my organisation the tients in need for kidney failure therapy will in- LNT wishes to emphasize in the immediate fu- crease in the future, both with respect to ture. haemodialysis and transplantation. There is The number of dialysis patients is strongly in- also a growing concern for increased treatment creasing. At the end of 2001 a total of 720 pa- capacity.5 tients received dialysis, (HD 621, PD 99) versus The next most important challenge lies in trans- 317 in 1997, ie. an increase of 127 per cent in 5 plantation immunology. Reducing the risk of years! rejection of the transplanted organ does not It is evident from these figures that something only involve using better immunosuppressive MUST be done to treat kidney failure! medicines. All transplanted patients are on life- Every dialysis patient costs close to 1 million long treatment with immunosuppressive Norwegian kroner (NOK) per year. The cost of medicines. These drugs have many serious un- transplantation is approximately 350.000 NOK, wanted side effects, both in the short and long medicines included, the first year. From this one run. The long time side effects include change cannot doubt that transplantations are cost-ef- of looks, osteoporosis, increased risk of cancer, fective both from the society's point of view as particularly skin cancer (such as malignant well as from the patients', and transplantation melanoma), and these side effects are basis for should therefore be the alternative of choice. great concern for the individual patient. The On January 1, 2002 a total of 230 were on a only acceptable alternative for the future seen waiting list for a replacement organ. This is from the patient's perspective, is to replace the more than a 35% increase compared with the failing organs with organs that are as similar as situation five years ago. This is a trend that is possible to the patient's own. expected to continue. 3. Stiftelsen Organdonasjon 2. The present challenge of organ Stiftelsen Organdonasjon is an umbrella organ- transplantation isation including six patient organisations. There is a very obvious tendency all over the Stiftelsen Organdonasjon carried out a large- western world that next of kin is not willing to ––––––– donate their organs to the relative in need. In 1 Torbjørn Leivestad, press release Rikshospitalet, 26.08. Norway the proportion of people refusing to 2002. 2 donate organs has increased from 25 per cent in Professor Svein Aage Christoffersen (chair of the Council on Animal Ethics), hearing of The Norwegian Biotechnol- 1 1994 to as much as nearly 40 per cent in 2001. ogy Board 1998. Acta vet. scand. Suppl. 99 - 2002 NKVet Proceedings 2002 61 scale information campaign during the spring tation of organs from one species to another, or of 2002 by enclosing donor cards in the infor- more specifically, from animals to humans). In mation brochure for the first time in Norway. It a world with screaming need for organs re- was released on the 19th of March, with the search has also focussed on the possibility to Minister of Health Mr. Dagfinn Høybråten breed genetically modified pigs from which or- signing the donorcard. Its primary goal is to in- gans could be harvested and used to replace crease public awareness of organ donations and sick human organs. These animals are not fit for the possibility for organ donation after death. human food consumption- and there are many Until now almost 1.5 million brochures have ethical considerations to be made in this re- been distributed, i.e. 3 million donor cards to spect. pharmacies, public libraries, doctors offices, I participated at the open hearing of the Norwe- hospitals etc. And the response was formidable, gian Biotechnology Board in September 1998 since almost 99 per cent of responders were entitled "Transplantation of organs from ani- supportive of organ donation after death and mals to humans- do we want this?" want to be of help. Most people at this hearing were positive to- wards medical progress in this field, but those The main causes of lack of organs are: that expressed a negative attitude, were the ex- • Far from all potential donors are identified at perts on contagious diseases. The large and un- the 27 certified donor hospitals in Norway known danger is the diseases that may cross • In many cases, even though the donors are species, that is, those swine diseases that may identified, the donation is not always carried infect humans through xenotransplantation. through, This problem has many aspects, and there is a • either, because the medical personnel find it risk that such disease may be transmitted with- too difficult to ask the family for permission, out detection at the 4th transplantation, but ap- • or, because donation is excluded due to lim- pear at the 100th, and then it is too late! Such ited resources at the hospital, diseases may pose a threat to mankind. And • or, because approximately 30-40% of next of then, what happens to those people that have re- kin refuse organ donation from their de- ceived a xeno-organ? ceased relative, most often because they do The consequences of xenotransplantations for not know the deceased's own attitude towards society should be further elucidated. While organ donation. xenotransplantation by many people is advo- Thus, the aim of Stiftelsen Organdonasjon is to cated as the ultimate solution to donor organ increase the number of donations from 17.6 to deficits, the discussion focussing on the donor 26 per million inhabitants annually, that is ap- potential of human organs is put behind in the proximately 120 donations per year! If this goal debate, a development, which worries me. Also is obtained, we are able to satisfy the total need the discussion in many ways has not empha- for organ donations in Norway. The last years sized the psychological consequences for the the number of donations per year has reached a recipient of a xeno-organ. How will he or she stable plateau of 65-70.
Recommended publications
  • Indian Mathematician O Born in Kerala, He Completed His Studies at the University of Nalanda O He Found Lengths of Chords of Circles
    III SEMESTER B.COM/BBA 3.8 SCIENCE AND SOCIETY Study Material Prepared By, Department of Commerce / Department of Business Administration 1 SYLLABUS Sl.no Name of the unit Pg. No 1 Introduction to Science 3 2 Modern Science and Its 30 Impact on Societies 3 Science, Life and 36 Livelihoods 2 UNIT-1 INTRODUCTION TO SCIENCE Some other common definitions of science: Systematized knowledge in general Any of the branches of natural or physical sciences A particular branch of knowledge The word Science comes from Latin word "scientia" meaning "knowledge" and in broadest sense it is any systematic knowledge-base or prescriptive practice being capable of resulting in prediction. Facets of Science: 1. Science is both a body of knowledge and a process 2. Science is exciting 3. Science is useful 4. Science is ongoing 5. Science is a global human endeavor HISTORY OF GREEK SCIENCE GREEK SCIENCE is strongly associated with Athens, because of Socrates, Plato and Aristotle. Aristotle inaugurates scientific zoology in his reliance on careful observation. He is particularly acute in his study of marine life, having much to say on the habits of fishes, the development of the octopus family, and the nature of whales, dolphins and porpoises. He is also a pioneer in attempting a system of classification. Observing an unbroken chain of gradual developments, as the life of plants shades into that of animals, he acknowledges the complexity of the subject and seems almost to glimpse the pattern of evolution. 3 Science 16th century 1543 – Copernicus: heliocentric model 1543 – Vesalius: pioneering research into human anatomy 1552 – Michael Servetus: early research in Europe into pulmonary circulation 1555 – Vesalius: no holes exist.
    [Show full text]
  • The Evolution of Special Education in Iowa As Told Through the Voices of Those Who Created It
    The Evolution of Special Education in Iowa As Told Through the Voices of Those Who Created It By Jeff Grimes and Jim Stumme 2016 The Evolution of Special Education in Iowa: As Told Through the Voices of Those Who Created It ii For Sharon Kurns who worked a lifetime helping others succeed iii Copying and Distribution The Evolution of Special Education in Iowa – As Told Through the Voices of Those Who Created It was written as a not-for-profit, free document. Readers are welcome to make copies. However, it is important to understand that the participants agreed to have their stories shared within the framework of this document, and likewise, many of the pictures and graphics were approved based on the context in which they are included. Thus, this document is to be viewed in its entirety, not as separate unconnected parts. The culture of caring in Iowa for enhancing special education services is to be celebrated as a whole across time and people. iv Contents Foreword .................................................................................................... vi Acknowledgments ....................................................................................... viii Introduction ................................................................................................. 1 Decades Before the 1960s ............................................................................ 14 Decade of the 1960s ................................................................................... 25 Decade of the 1970s ..................................................................................
    [Show full text]
  • Forskningens Genombrott Innehåll Jubileumsnumret
    JUBILEUMSNUMMER 2014 Hjärt-Lungfonden fi rar jubileum Forskningens genombrott Innehåll jubileumsnumret 4 SCAPIS. En unik forskningsstudie Forskningshistoria skapar nästa genom- 1904. En helt annan tid. Då lungsoten, brott. tuberkulosen, var en stor skräck i Sverige och tusentals dog i sjukdomen 6 Tuberkulos. Den his- varje år. Jag tänker på den tiden och på toriska kraftsamling- mina företrädare, som tog initiativet en som gav resultat. till Svenska Nationalföreningen mot Tuberkulos. De hade en vision, att utro- 12 Hjärtkirurgi. Hjärt- ta tuberkulosen som folksjukdom, men kirurgin har upplevt de hade inte den blekaste aning om hur många milstolpar. Hjärtkirurgi.Anders Jeppsson är mycket den visionen skulle betyda så hjärtkirurg och ser en snabb utveck- långt fram i tiden som 2014. 16 Pacemaker. En 14 ling av olika operationstekniker. Tuberkulosen slutade vara det stora svensk uppfi nning dödshotet i Sverige. I dag är vår vision gav miljoner ett nytt att besegra både hjärt- och lungsjuk- liv. Perspektiv. domarna, och vi är på god väg, mycket Nina Rehnqvist tack vare den otroligt framgångsrika 18 Perspektiv. Nina imponeras av forskningen! Rehnqvist har följt de framsteg Jag vill uppmana dig att läsa och hjärtvårdens utveck- som ägt rum. glädjas åt alla fantastiska upptäckter ling. som har gjorts genom åren och som i dag räddar många tusen liv. Jag talar 22 PCI och stent. Fler om vaccin mot tuberkulos, om hjärt- överlever hjärtinfarkt lungmaskinen, pacemakern, möjlighe- med ballongvidgning. ten att transplantera både hjärtan och lungor, om ballongvidgningar och stent 27 Transplantation. I och om en rad läkemedel som gör livet framtiden hoppas 18 lättare för alla drabbade.
    [Show full text]
  • To Clinical Xenogeneic Heart Transplantation. Presented at the 15Th Biannual IXA Meeting, Munich, October 11, 2019
    Received: 23 June 2020 | Accepted: 30 July 2020 DOI: 10.1111/xen.12637 REVIEW ARTICLE On the way (my way) to clinical xenogeneic heart transplantation. Presented at the 15th biannual IXA meeting, Munich, October 11, 2019 Bruno Reichart1 | Matthias Längin2 1Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, Munich, Germany 2Department of Anaesthesiology, University Hospital, LMU Munich, Munich, Germany Correspondence: Bruno Reichart, Walter Brendel Centre of Experimental Medicine, LMU Munich, Marchioninistraße 27, 81377 Munich, Germany. Email: [email protected] 1 | PRECLINICAL AND At the Ludwig-Maximilians University in Munich, Walter Brendel CLINICAL CONCORDANT HEART (1922-1989) became Head of the Department of Experimental XENOTRANSPLANTATION Surgery (now the “Walter Brendel Center for Experimental Medicine”). During most of the 1960s till the first half of the 1980s, The first heart replacement in humans was a xenograft. On January xenotransplantation remained one of his main interests—and that 23, 1964, James Hardy (1918-2003) from Mississippi, USA, re- of his consultant and chief investigator Claus Hammer (1940-2015). moved the heart of a dying 68-year-old adult and replaced it with The latter characterized preformed natural antibodies (PNABs)4 in the organ of a small chimpanzee. After 90 minutes, the transplant sera of 48 species from seven zoological orders and investigated stopped beating, because it was of course too small.1 Hardy was more than 8300 combinations of serum samples and antigens of heavily criticized by both the public and his medical peers—partly 111 individuals. Among others, his key finding was that PNABs were unfair since he and his team had prepared the intervention care- absent or low between the species within a zoological family (con- fully over years; he should, however, have selected a better first cordant systems) such as domestic dogs, foxes and dingos; domestic recipient.
    [Show full text]
  • Members of the DRC Research Base Order of Biopages
    Members of the DRC Research Base Order of Biopages Name Academic Membership DRC Area of Excellence Department Category Affuso, Olivia Thomas, PhD Epidemiology Scientist Interventions/Trials Agarwal, Anupam, MD Med/Nephrology Senior Scientist Diabetes Complications Akinyemiju, Tomi F., PhD Epidemiology Mentored Interventions/Trials Allison, David B, PhD Nutrition Sciences Senior Scientist Epidemiology/Genetics Allon, Michael, MD Med/Nephrology Scientist Diabetes Complications Arend, Rebecca, MD OB/GYN Scientist Diabetes Complications Arora, Pankaj, MD, FAHA Med/Cardiology Mentored Epidemiology/Genetics Ashraf, Ambika P, MD Peds/Endocrinology Scientist Integrative Metabolism Aslibekyan, Stella, PhD Epidemiology Mentored Epidemiology/Genetics Austad, Steven N., PhD Arts & Sci/Biology Senior Scientist Integrative Metabolism Bae, Sejong, PhD Med/Preventive Med Scientist Diabetes Complications Bailey, Shannon M, PhD Pathology Senior Scientist Integrative Metabolism Ballinger, Scott W, PhD Pathology Senior Scientist Vascular Disease Bamman, Marcas M, PhD Cell Biology Senior Scientist Integrative Metabolism Banerjee, Ronadip Ralph Med/Endocrinology Mentored Islet Biology/Autoimmunity Barnes, Stephen, PhD Pharmacology Senior Scientist Integrative Metabolism Bartolomeo, Maria A. Grant, MD Ophthalmology Senior Scientist Diabetes Complications Baskin, Monica L, PhD Med/Preventive Med Senior Scientist Interventions/Trials Bebok, Zsuzsanna, MD Cell Biology Senior Scientist Molecular Signaling Bevensee, Mark O., PhD Cell Biology Senior Scientist Molecular
    [Show full text]
  • Cardiac Transplantation: Since the first Case Report
    Grand Rounds Vol 4 pages L1–L3 Speciality: Landmark Case Report Article Type: Original Case Report DOI: 10.1102/1470-5206.2004.9002 c 2004 e-MED Ltd GR Cardiac transplantation: since the first case report S. M. Benjamin and N. C. Barnes Department of Respiratory Medicine, London Chest Hospital, London, United Kingdom Corresponding address: S M Benjamin, Department of Respiratory Medicine, London Chest Hospital, London, United Kingdom. E-mail: [email protected] Date accepted for publication 1 March 2004 Abstract Heart transplantation was and is still recognised as a medical milestone. Its ability to offer a second chance of life to people with end-stage cardiac disease is its major triumph. Dr Christiaan Barnard’s work was instrumental in realising the actual possibility of conducting a human transplant, and provided the framework for further advances in this field. He deserves due credit for conducting the first successful human heart transplant. Keywords Cardiac transplantation. Introduction Heart transplantation is one of the most widely publicised medical advances in the last century. Dr Christiaan Barnard accomplished this historic medical feat on December 3, 1967. The potentially life-saving operation immediately captured worldwide attention, lauding him with much deserved praise for his outstanding work in this field. Heart transplants Earlier experiments in heart transplantation were carried out in laboratories using canine models. As early as 1905, Alexis Carrel and Charles Guthrie [1, 2] first attempted transplanting the heart of a puppy into the neck of an adult dog. The heterotopic heart immediately resumed cardiac contractions lasting approximately 2 h. Dr Norman Shumway and Dr Richard Lower of Stanford University performed the first orthotopic heart transplant in 1960 applying principles of topical hypothermia for graft preservation and immunosuppression in order to prolong graft survival times.
    [Show full text]
  • The World's First Human-To-Human Heart Transplant at Groote Schuur
    This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0. GUEST EDITORIAL The world’s first human-to-human heart transplant at Groote Schuur Hospital: 50 years later Fifty years ago, on 3 December 1967, the world’s first human-to-human heart transplant was performed by Dr Christiaan Barnard at Groote Schuur Hospital in Cape Town. This was, and probably will remain, the most publicised medical event of all time, making headlines in nearly every international newspaper, magazine and tabloid within days of the event. The idea of transplanting a heart from one human to another captured the minds and imaginations of the public like no other medical event before or since. The only other iconic event in that era that was equally well publicised was man’s first landing on the moon 18 months later. This medical breakthrough was published in the SAMJ 3 weeks later, towards the end of December 1967, and is one of the most cited articles in this journal. The first heart transplant placed Groote Schuur Hospital, the University of Cape Town and South Africa (SA) firmly on the international medical map. A heart transplant was seen by the public as transplanting the very soul of an individual from one person into another. It provoked tremendous debate, some of it very emotional, around the ethics of transplantation and spurred on the international medical and philosophy community to develop the concept of brain death into law. Many countries took decades to adopt such laws – most notably Japan, which took another 30 years (until 1997) to allow organ transplantation from brain-dead donors.
    [Show full text]
  • Chris Barnard
    Commentary Page 1 of 4 Chris Barnard: South Africa’s fallible king of hearts AUTHOR: 1 Marina Joubert On 3 December 1967, a South African surgeon stunned the world when he performed the first human heart transplant in Cape Town’s Groote Schuur Hospital – a dramatic story that has been told numerous times. Here, I AFFILIATION: will focus on the central character – Chris Barnard – and his rise to global celebrity status. 1Centre for Research on Evaluation, Science and Barnard started from humble beginnings. He was born on 8 November 1922 in Beaufort West and grew up in a Technology (CREST), poor family. After school he studied medicine at the University of Cape Town and obtained his MSc and PhD from Stellenbosch University, the University of Minnesota. He was 45 years old when he made medical history and was swept up by a vortex of Stellenbosch, South Africa worldwide fame. His bold surgical feat triggered his rise to celebrity, but there was more to Barnard’s lasting allure.1 Scholars who have studied the phenomenon of celebrity within science suggest that a contingent association of CORRESPONDENCE TO: factors contribute to the process of celebrification.2-5 When all these factors occur simultaneously, serendipity takes Marina Joubert over and it appears as if an invisible hand runs a publicity campaign on behalf of the scientist.3 Barnard’s life was a case in point. EMAIL: [email protected] How Barnard measures up to Goodell’s view of visible scientists In the early 1970s, American sociologist Rae Goodell conducted a landmark study of visible scientists.2 Deploying KEYWORDS: the concepts of ‘visibility’ and ‘celebrity’ synonymously,6 Goodell classified a new type of public scientist that visible scientists; emerged at the time, mainly as a result of the rising power of the mass media.
    [Show full text]
  • History of Heart Transplantation: a Hard and Glorious Journey
    SPECIAL ARTICLE - HISTORIC Braz J Cardiovasc Surg 2017;32(5):423-7 History of Heart Transplantation: a Hard and Glorious Journey Noedir A. G. Stolf1, MD, PhD DOI: 10.21470/1678-9741-2017-0508 INTRODUCTION contractions were seen. Afterward contractions appeared and about an hour after the operation, effective contractions of This year we celebrate 50 years of the first interhuman heart the ventricles began. The transplanted heart beat at the rate of transplantation. So, I believe that it is interesting to review the 88 per minute, while the rate of the normal heart was 100 per most important steps of this glorious journey. minute. A little later tracing was taken. Owing to the fact that Heart transplantation first performed in the course of the operation was made without aseptic technique, coagulation experiments of other nature in the beginning of 20th century, occurred in the cavities of the heart after about two hours, and seen as a speculation for the future in the middle of the same the experiment was interrupted”. century, is now widely accepted by medical and lay communities Although the exact details of experiments were not known as a valuable therapeutic procedure. the most probable arrangement of anastomosis are shown in This history can be divided into an experimental and a Figure 1 adaptation in a book by Najarian and Simmons[2]. The clinical heart transplantation periods, with the first one in problem with this model is that arterial inflow is in the atrium heterotopic non-auxiliary, heterotopic auxiliary and orthotopic and aortic outflow is under venous pressure, in other words, transplantations.
    [Show full text]
  • Transplant Updates
    Heart Transplantation A Half Century of Progress April 6, 2019 David D’Alessandro, M.D. Surgical Director, Cardiac Transplantation and Mechanical Circulatory Support Disclosures • None 2 Heart Transplantation • How did we get there? • How far have we come? • Where are we going? The danger of touching the heart "Surgery of the heart has probably reached the limits set by Nature to all surgery. No method, no new discovery, can overcome the natural difficulties that attend a wound of the heart." Stephen Paget, 1896 Alexis Carrel • published his technique for the vascular anastomosis in 1902 • 1905 reported heterotopic kidney and heart transplantation in dogs • Nobel Prize in Physiology 1912 History of Cardiac History Evolution of CPB Early Challenges in Cardiac Surgery 1920s - 1950s • Multiple failed attempts at operative treatment of rheumatic mitral stenosis • Poor visualization during ASD repairs Tubbs dilator Heart Lung Machine John Gibbon 1953 Cecilia Brevolek: May 6th as the first successful truly open-heart operation performed with the use of a heart-lung machine. Norman Shumway Surg Forum 1960;11:18. James Hardy • First human cardiac transplant was a chimpanzee xenograft performed at the University of Mississippi in 1964. Operative Permit Public ridicule “…not only immoral, but amoral”. Richard Lower • 1966 Lower performed “a reverse Hardy” • Passed up an opportunity to perform a human to human transplant in 1966 due to over cautious concern about secondary incompatibility Christiaan Barnard Louis Washkansky (December 3, 1967) “My moment of truth – the moment when the enormity of it all really hit me – was just after I had taken out Washkansky’s heart.
    [Show full text]
  • 10 December 2015 Cape Town, South Africa Contents
    7 – 10 December 2015 Cape Town, South Africa Contents Welcome Message from the President of the IEEE Computational Intelligence So- ciety 6 Welcome Message from the General Chair of IEEE SSCI'15 7 2015 Frank Rosenblatt Award 9 Organizing Committee 10 Symposium Chairs 13 ADPRL.............................................. 13 CCMB............................................... 14 CIASG .............................................. 15 CIBD ............................................... 15 CIBIM............................................... 16 CICA ............................................... 16 CICARE . 17 CICS................................................ 17 CIComms . 18 CIDM............................................... 18 CIDUE .............................................. 19 CIEL ............................................... 19 CIES................................................ 20 CIFEr............................................... 21 CIHLI............................................... 21 CIPLS............................................... 22 CIR2AT.............................................. 22 CISched . 23 CIVTS............................................... 23 EALS ............................................... 24 FOCI ............................................... 24 IA ................................................. 25 ICES................................................ 26 IntECS .............................................. 26 MCDM .............................................. 27 RiiSS ..............................................
    [Show full text]
  • Advanced English Reading and Comprehension
    PRACTICE MAKES PERFECT® Advanced English Reading and Comprehension Also by Diane Engelhardt Practice Makes Perfect: Intermediate English Reading and Comprehension Perfect Phrases for ESL: Conversation Skills PRACTICE MAKES PERFECT® Advanced English Reading and Comprehension Diane Engelhardt New York Chicago San Francisco Athens London Madrid Mexico City Milan New Delhi Singapore Sydney Toronto Copyright © 2013 by McGraw-Hill Education. All rights reserved. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the publisher. ISBN: 978-0-07-179887-7 MHID: 0-07-179887-0 The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-179886-0, MHID: 0-07-179886-2. All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the beneit of the trademark owner, with no intention of infringement of the trademark. Where such designations appear in this book, they have been printed with initial caps. McGraw-Hill Education eBooks are available at special quantity discounts to use as premiums and sales promotions or for use in corporate training programs. To contact a representative, please visit the Contact Us page at www.mhprofessional.com. TERMS OF USE This is a copyrighted work and McGraw-Hill Education and its licensors reserve all rights in and to the work.
    [Show full text]